Calcium (Ca 2+ )-activated chloride (Cl 2 ) channels (CaCCs) play a role in the modulation of action potentials and synaptic responses in the somatodendritic regions of central neurons. In the vertebrate retina, large Ca 2+ -activated Cl 2 currents (I Cl(Ca) ) regulate synaptic transmission at photoreceptor terminals; however, the molecular identity of CaCCs that mediate I Cl(Ca) remains unclear. The transmembrane protein, TMEM16A, also called anoctamin 1 (ANO1), has been recently validated as a CaCC and is widely expressed in various secretory epithelia and nervous tissues. Despite the fact that tmem16a was first cloned in the retina, there is little information on its cellular localization and function in the mammalian retina. In this study, we found that ANO1 was abundantly expressed as puncta in 2 synaptic layers. More specifically, ANO1 immunoreactivity was observed in the presynaptic terminals of various retinal neurons, including photoreceptors. I Cl(Ca) was first detected in dissociated rod bipolar cells expressing ANO1. I Cl(Ca) was abolished by treatment with the Ca 2+ channel blocker Co 2+ , the Ltype Ca 2+ channel blocker nifedipine, and the Cl 2 channel blockers 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) and niflumic acid (NFA). More specifically, a recently discovered ANO1-selective inhibitor, T16A inh -A01, and a neutralizing antibody against ANO1 inhibited I Cl(Ca) in rod bipolar cells. Under a current-clamping mode, the suppression of I Cl(Ca) by using NPPB and T16A inh -A01 caused a prolonged Ca 2+ spike-like depolarization evoked by current injection in dissociated rod bipolar cells. These results suggest that ANO1 confers I Cl(Ca) in retinal neurons and acts as an intrinsic regulator of the presynaptic membrane potential during synaptic transmission.
Introduction
Calcium (Ca 2+ )-activated chloride (Cl 2 ) channels (CaCCs) are anion-selective channels that are activated by increased cytosolic Ca 2+ . CaCCs have been implicated in many important physiological processes, such as the transepithelial transport of electrolytes and water, control of vascular tone, and cardiac muscle and neuronal excitability [1] [2] [3] [4] . In the nervous system, Ca 2+ -activated Cl 2 current (I Cl(Ca) ) is primarily observed in primary sensory neurons, such as olfactory receptor neurons (ORNs), taste receptor cells, somatosensory neurons of dorsal root ganglia (DRG), and photoreceptors of the retina, and is involved in corresponding sensory transduction. I Cl(Ca) is also found in presynaptic terminals in the brain, where it is thought to modulate synaptic activity [1] .
Anoctamin 1 (ANO1, also called TMEM16A) [5] [6] [7] is a CaCC because its biophysical and pharmacological characteristics correspond to those of endogenous CaCCs [8, 9] . The identification of ANO1 as a CaCC has unveiled its significance in many physiological activities, including (1) Cl 2 transport in airways [5, 10, 11] , salivary glands [7, 12] , and gastrointestinal epithelial cells [13, 14] , (2) rhythmic contraction in gastrointestinal tracts [13] [14] [15] , and (3) heat sensation in DRG neurons [16] .
The retina is a well-characterized model system that is used for the study of synaptic mechanisms, as it contains various neurotransmitters found in the central nervous system and its receptors; various types of synapses, such as conventional chemical, electrical, and distinct ribbon synapses; and several well-established synaptic circuits for visual processing. I Cl(Ca) has been characterized in the photoreceptors of the vertebrate retina [17, 18] and is thought to regulate synaptic transmission at photoreceptor terminals by stabilizing membrane potentials and Ca 2+ channel modulation [19] [20] [21] [22] [23] [24] . Recently, ANO1 [25] and ANO2 [26] , which is another anoctamin with CaCC characteristics [27] , were identified in photoreceptor terminals in salamander and mouse retinas, respectively. They are thought to be strong candidates for the molecular identity of I Cl(Ca) in photoreceptors. However, their specific functions in photoreceptors are not known in the mammalian retina. In addition, I Cl(Ca) has been identified in goldfish bipolar cells [28] , which are another type of retinal neuron. These findings suggest the presence of I Cl(Ca) in other retinal neurons, even though its molecular identity and function remain unknown. Thus, we sought to examine the expression, localization, and function of ANO1 in the mouse retina.
Results

Expression and localization of ANO1 in the retina
To investigate the expression and distribution pattern of the ANO1 protein in the mouse retina, western blotting and immunohistochemistry were performed. As shown in Fig. 1A , an ANO1 immunoreactive band (,130 kDa) was recognized in both the retina and salivary gland (the latter was used as a control tissue in which ANO1 is expressed abundantly) [7, 12] . Strong ANO1 immunoreactivity was observed as puncta in 2 synaptic layers, the outer plexiform layer (OPL) and the inner plexiform layer (IPL), whereas weak immunoreactivity was detected in some somata in the inner nuclear layer (INL) and ganglion cell layer (GCL). There was no immunoreactivity in the outer nuclear layer (ONL) (Fig. 1B) .
Next, we determined the cellular and subcellular localization of ANO1 in the retina via double-labeling experiments using various neuronal and synaptic markers. ANO1 puncta in the OPL, where photoreceptor terminals synapse onto bipolar and horizontal cell dendrites, showed immunoreactivities for synaptophysin and vesicular glutamate transporter 1 (VGLUT1), which are markers of photoreceptor terminals (Figs. 2A and B), but not for Goa, which is an ON bipolar cell marker (Fig. S1A) , and calbindin, a horizontal cell marker (Fig. S1B) . These results indicate that ANO1 is expressed in photoreceptor terminals, but not in bipolar and horizontal cell dendrites. In the IPL, where bipolar axon terminals synapse onto ganglion cell dendrites and amacrine processes, which in turn give synaptic inputs to ganglion dendrites and bipolar terminals, ANO1 was detected in bipolar cell terminals that were immunoreactive for VGLUT1, which is a bipolar terminal marker (Fig. 2C) , and in amacrine cell processes that were immunoreactive for vesicular GABA transporter (VGAT), which is an amacrine terminal marker (Fig. 2D ), but not in ganglion cell dendrites exhibiting immunoreactivity for SMI32, which is a ganglion cell marker (Fig. S1C) .
In vertical retinal sections, large and strongly labeled ANO1 puncta exhibiting VGLUT1 immunoreactivity were observed in the IPL, close to the GCL (Fig. 2C) . This is where stratification of the axon terminals of rod bipolar cells, which are a subpopulation of second-order neurons involved in processing scotopic vision [29] , occurs. Thus, we confirmed that ANO1 is expressed in rod bipolar axon terminals in retinal slices (Fig. 3A ) and dissociated cells (Fig. 3B) , as assessed via double-labeling of ANO1 and PKC, which is a marker for rod bipolar cells. Taken together, our results suggest that ANO1 is expressed in various retinal neurons, including rod bipolar cells, and that ANO1 is preferentially localized to the presynaptic region.
We used pre-embedding immunoelectron microscopy to confirm the presynaptic localization of ANO1 in retinal neurons. In the OPL, cone pedicles and rod spherules were labeled for ANO1, whereas invaginating ON-bipolar and horizontal cell dendrites, which are postsynaptic elements located at the ribbon synapse of photoreceptor terminals, and OFF-bipolar cell dendrites, which make basal junctions with cone pedicles, were unlabeled (Figs. 4A and B). In the IPL, ANO1 labeling was observed in some bipolar terminals (Fig. 4C) , including rod bipolar cells, which were identified by their synaptic ribbons, and amacrine processes, which were filled with synaptic vesicles and established conventional chemical output synapses (Fig. 4D) . However, ganglion cell dendrites, which contain microtubules and microfilaments instead of synaptic vesicles, were not immunolabeled (Fig. 4C) . These results were consistent with confocal microscopy findings, as shown in Figs. 2 and 3, and confirmed the preferential presynaptic localization of ANO1 in various retinal neurons.
Identification and characterization of I Cl(Ca) in rod bipolar cells expressing ANO1
Our anatomical findings strongly imply the presence of ANO1 in rod bipolar cells. However, the presence and functions of CaCCs and/or I Cl(Ca) mediated by CaCCs have not been reported in rod bipolar cells in the mammalian retina (however, please refer to a previous report of I Cl(Ca) in a bipolar cell type in the goldfish retina [28] ). Thus, we aimed to test whether I Cl(Ca) is present in mouse rod bipolar cells, and to characterize this current.
Whole-cell currents were recorded from somata ( Fig. 5A ; n = 20) and axon terminals ( Fig. 5B ; n = 7) of freshly dissociated rod bipolar cells, including long axons and terminals. The kinetics of the 2 currents were almost identical, as seen in Fig. 5 . Upon depolarizing the cells to the voltage of +10 mV from a holding potential of 285 mV, inward current was generated, followed by a slowly inactivating tail current (I tail ) (Figs. 5A and B ). This inward current was identified as L-type Ca 2+ current (I Ca ), which was described previously in rod bipolar cells [30, 31] , because (1) potassium currents and h-current were suppressed by tetraethylammonium chloride (TEA) and CsCl; (2) it was detectable at depolarizing potentials between about 260 mV and +40 mV and had a peak amplitude of 2064 pA at a voltage of about 230 mV; and (3) it was sensitive to nifedipine, which is L-type Ca 2+ channel antagonist (Fig. S2) . I tail was also detectable; its activation started at about 230 mV and peaked at about +10 mV. The maximum amplitude was ,30 pA and I tail lasted for ,1 s.
To test whether the activation of I tail was dependent on I Ca , a solution containing no Ca 2+ and 3 mM Co 2+ (Ca 2+ channel blocker) were applied in series as shown in Fig. 5C (n = 13). In this series of recordings, both I Ca and I tail were not found in the absence of Ca 2+ , were recovered in control solution, and were suppressed again in the presence of 3 mM Co
2+
. Next, we tested whether Ba 2+ activated I tail as a carrier that permeates the Ca 2+ channels ( Fig. 5D ; n = 10). I tail was abolished by the replacement of external Ca 2+ with equimolar Ba 2+ , whereas I Ca was enhanced because of Ba 2+ conductance. Moreover, the intracellular [Ca 2+ ] i dependency of I tail was tested by the application of Ca 2+ chelators in the pipette solution. The introduction of both BAPTA (. 10 mM) (n = 8) and EGTA (5 mM) (n = 8) into bipolar cells via a recording pipette strongly suppressed I tail (Fig. S3) . Furthermore, we applied BAPTA/AM (0.1 mM), which is a membrane-permeable Ca 2+ chelator, extracellularly ( Fig. 5E ; n = 8). During the treatment with BAPTA/AM, the peak amplitude (40.368 (Fig. 6A, right panel) . Thus, the major component of this I tail was identified as a Cl 2 current. However, this Cl 2 conductance may have been due to the activation of glutamate transporters in the retina [32] . To rule out this possibility, we applied a glutamate transporter inhibitor, DL-threo-b-benzyloxyaspartate (DL-tBOA). Blocking the glutamate transporter did not induce a significant change in I tail (n = 8; data not shown), suggesting that the portion of Cl 2 conductance that is mediated by the this transporter is negligible in the major component of this I tail .
Finally, we tested the effect of various Cl 2 channel blockers on I tail ; 100 mM NPPB, 100 mM NFA, 1 mM 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), and 2 mM SITS ( Fig. 6B ; n = 10 for each blocker). Among the extracellular application of those blockers, NPPB (90.7610.0%) and NFA (79.867.3%) significantly suppressed the peak amplitude of I tail without a reduction in I Ca . Although this I tail exhibited a lower sensitivity to DIDS (62.4612.2%) and SITS (61.2610.8%), these results suggest that I tail detected in rod bipolar cells is I Cl(Ca) .
ANO1 is the CaCC that mediates I Cl(Ca) in rod bipolar cells
We performed 2 experiments to confirm that ANO1 is the molecular identity of I Cl(Ca) observed in rod bipolar cell. First, we applied a specific ANO1 inhibitor, T16A inh -A01 [33] , which is the most recent commercially available ANO1 inhibitor. As this was the first attempt to apply T16A inh -A01 to retinal bipolar cells, we determined whether it acts as a specific blocker in these cells in a dose-dependent manner. The resulting dose-response curve showed that T16A inh -A01 inhibited I Cl(Ca) in response to depolarizing voltage steps in a dose-dependent manner, with a half-maximal dose (EC 50 ) of 3 mM. Upon applying the effective dose of 10 mM, an apparent inhibition of I Cl(Ca) was observed without any effects on I Ca ( Fig. 7A ; n = 12).
Next, the neutralizing effects of ANO1 were assessed using a specific antibody against ANO1, via direct addition to the pipette solution (Fig. 7B) . The anti-ANO1 antibody was developed against a peptide in the first intracellular loop between transmembrane domains 2 and 3 of mouse ANO1 as a target [7, 12] . The first intracellular loop of ANO1 has recently been determined as being the critical region for voltage-and Ca 2+ -dependent gating [34] . To rule out the possibility that the anti-ANO1 effect may have arisen from the antibody itself, we tested 2 other antibodies, as negative controls: an anti-glial fibrillary acidic protein (GFAP) antibody ( Fig. S4 ; n = 11) and a peroxidase-conjugated donkey anti-rabbit antibody (n = 11; data not shown). The application of these negative-control antibodies elicited in no significant changes in either I Ca or I Cl(Ca) . However, the application of the anti-ANO1 antibody had a strong blocking effect on I Cl(Ca) (20. 164.1%), without changing I Ca (99.5614.6%), when current traces observed at ,3 min were compared with those recorded at ,10 min; the black traces were control traces recorded prior to the full diffusion of the anti-ANO1 antibody into the cell (,3 min post-rupture), and the colored traces depicted the neutralizing effect of ANO1 via the addition of the anti-ANO1 antibody to the pipette solution (,10 min post-rupture) (n = 12; data not shown). We further verified the blocking effect of the anti-ANO1 antibody on I Cl(Ca) (14. 
ANO1 shortens Ca
2+ spike-like depolarization duration in rod bipolar cells
To investigate the possible function of ANO1 on rod bipolar cells, we recorded membrane potentials using the current-clamp mode in gramicidin-perforated whole cells. It has been demonstrated that rod bipolar cells dissociated from the mammalian retina exhibit membrane potentials of about 245 mV [35] [36] [37] and E Cl measured in rod bipolar cell axon terminals is about 260 mV [38] . The application of depolarizing currents (0.05,0.1 nA) to cells resting near 245 mV (n = 14) led to the observation of a distinct Ca 2+ spike-like depolarization in isolated rod bipolar cells (Figs. 8A and C). This waveform consisted of a first few huge spikes and subsequent small spikes riding atop a plateau potential that was similar to an excitatory postsynaptic potential. The application of 100 mM NPPB and T16A inh -A01 to the bath (Figs. 8A and C; n = 11 for each) revealed that the very first spike was maintained, whereas the depolarizing potential waveform was prolonged. The measurement of the width of the waveform at 1/2 total spike height showed that the application of NPPB and T16A inh -A01 augmented the width of current-evoked response potential by ,60% compared with that observed in the absence of the drugs (Figs. 8B and D) . Interestingly, EC 50 of in increasing the width was similar to EC 50 
Discussion
This study documented the expression of ANO1, a CaCC, in the retina. This was the first demonstration of the presence of I Cl(Ca) in rod bipolar cells, which are a specific type of retinal neurons that express ANO1, and its possible function. Our results showed that (1) various retinal neurons expressed ANO1; (2) this protein was exclusively localized in the presynaptic region; (3) rod bipolar cells expressing ANO1 conferred I Cl(Ca) , which was blocked by T16A inh -A01 (a selective ANO1 inhibitor) and a neutralizing antibody; and (4) NPPB and T16A inh -A01 prolonged the distinct Ca 2+ spike-like depolarization evoked by current injection in dissociated rod bipolar cells. These results suggest that ANO1 acts as an intrinsic regulator of the presynaptic membrane potential during synaptic transmission in retinal neurons.
In sensory neurons, CaCCs are localized in somatodendritic regions and are involved in signal transduction and amplification, ANO1 activation leads to depolarization in DRG neurons and acts as a heat sensor [16] , whereas ANO2 contributes to signal amplification of olfactory sense in ORNs [39, 40] . In addition, Huang et al. [41] have demonstrated that ANO2 is localized in the close vicinity of voltage-gated Ca 2+ channels and NMDA receptors in the somatodendritic region in hippocampal neurons, where it regulates action potentials and synaptic responses. Thus, CaCCs appear to play important functions in receptive and/or postsynaptic regions in neurons.
We showed that ANO1 was strongly expressed in 2 synaptic layers. Double-labeling experiments using various pre-and postsynaptic markers and immunoelectron microscopy clearly showed that ANO1 was localized to presynaptic terminals such as photoreceptor terminals, bipolar axon terminals, and amacrine cell processes. This preferential presynaptic localization of ANO1 was also observed in the cochlea, where ANO1 is exclusively localized at medial olivocochlear efferent nerve endings [42] , and in the cerebellum where ANO1 is mainly found in mossy fibers (our unpublished data). Furthermore, when we performed wholecell voltage clamp recordings on a rod bipolar cell without the axon terminal, which is often lost during the procedure of enzymatic dissociation, I Cl(Ca) was hardly elicited (Fig. S5) , suggesting that I Cl(Ca) may originate from the axon terminal and/or be linked with the Ca 2+ channels localized at the axon terminal. These findings suggest that CaCCs also have important functions in presynaptic terminals in neurons. In fact, the exclusive presynaptic localization of ANO1 in photoreceptor terminals observed in this study concurs with previous reports that showed that I Cl(Ca) is elicited by depolarization-evoked Ca 2+ influx, which ] o condition (n = 16). I Ca and I Cl(Ca) were recorded in the presence of the anti-ANO1 antibody in the pipette solution in response to depolarizing pulses ,3 min after rupture and ,10 min after rupture, respectively. The panel on the right depicts the comparison of the amplitude changes of I Ca and I Cl(Ca) between ,3 min after rupture and ,10 min after rupture. The results of statistical analyses are presented as the normalized mean 6 S.D.. Student's t-tests were used to compare the data from the 2 groups. Significance was set at P,0.05 (*) and P,0.01 (**). doi:10.1371/journal.pone.0067989.g007
activates CaCCs localized at photoreceptor terminals [17, 18, 25, 38] , and supports the proposed role of I Cl(Ca) in membrane potential stabilization during synaptic activity [19, 20, 22, 43] and presynaptic Ca 2+ channel modulation [23] [24] [25] . In this study, the abundant expression of ANO1 detected in various retinal neurons, such as photoreceptors and bipolar and amacrine cells, exceeded our expectations. For example, the presence of I Cl(Ca) in mouse rod bipolar cells has not been described previously, even though many studies on Ca 2+ channel properties [30, 31] and Ca 2+ tail currents [44, 45] have been performed to understand visual signal processing and synaptic transmission in mammalian rod bipolar cells. The reasons for this may be that I Ca amplitude that causes I Cl(Ca) is too small in mouse rod bipolar cells and that the studies mentioned above focused on the detection and characterization of I Ca itself. In this study, we found that ANO1 was expressed in rod bipolar cells; hence, we anticipated the presence of I Cl(Ca) in these cells. To facilitate the identification of I Cl(Ca) , we lowered the concentration of the Ca 2+ chelator (0.5 mM EGTA) compared with that used in previous studies (5 mM EGTA) [30, 31, 46] . In these conditions, we were able to identify I Cl(Ca) in rod bipolar cells easily and successfully. In fact, using this protocol (0.5 mM EGTA), I Cl(Ca) was identified in goldfish retinal bipolar cells [28] after I Ca identification [46, 47] . Thus, to detect the presence and identify the function of CaCCs that are underestimated in the nervous system, further studies aimed at identifying CaCC conductance in other central neurons by using our protocol are needed.
Here, the suppression of CaCC using NPPB, which is a CaCC blocker, and T16A inh -A01, which is a selective ANO1 blocker, prolonged the current-evoked depolarization that was experimentally induced by us. These results provide a very critical piece of information that explains the possible roles of I Cl(Ca) mediated by ANO1 in rod bipolar cells. The dissociated preparation can be considered as a condition in which the synaptic network is free (i.e., synaptic events do not occur between presynaptic and postsynaptic neurons), but in which the intrinsic properties of the recording cells are preserved. The function of CaCCs may depend on their spatial distribution in cells and on local differences in E Cl . Notably, to establish the function of I Cl(Ca) , it is crucial to know E Cl . CaCCs promote membrane depolarization in rod photoreceptor terminals, where E Cl is <220 mV and the membrane potential is estimated at ,245 mV [48] . Conversely, mouse rod bipolar cells, which receive synaptic inputs from rods, have E Cl (<260 mV) that is more negative than the resting membrane Figure 8 . The physiological role of I Cl(Ca) during membrane depolarization was examined using NPPB and T16A inh -A01. A. The bipolar cell membrane potential was adjusted to close to 245 mV with a steady hyperpolarizing current. A distinctive slow depolarizing potential that followed the Ca 2+ -dependent transient potentials was elicited by a current injection of 0.5 nA for 200 ms (n = 11). The extracellular application of 100 mM NPPB enhanced the depolarizing membrane potential compared with the control experiment. B. The dose-dependent decrease elicited by NPPB on I tail amplitude obtained under the voltage-clamping mode (gray) was compared with the dose-dependent increase elicited by NPPB on the width of current-evoked spikes (red). The half-maximal dose (EC 50 ) of NPPB that was necessary to increase the width was similar to EC 50 of NPPB that inhibited I Cl(Ca) (15.0 vs. 18.4 mM). C. In addition, T16A inh -A01 application enhanced the depolarizing membrane potential (n = 8). D. The dosedependent decrease elicited by T16A inh -A01 on I tail amplitude obtained under the voltage-clamping mode (gray) was compared with the dosedependent increase elicited by T16A inh -A01 on the width of current-evoked spike (blue). The half-maximal dose (EC 50 ) of T16A inh -A01 that was necessary to increase the width was similar to EC 50 of T16A inh -A01 that inhibited I Cl(Ca) (2.6 vs. 3.0 mM). Significance was set at P,0.05 (*) and P,0.01 (**). doi:10.1371/journal.pone.0067989.g008 potential (<245 mV) at its presynaptic axon terminal [38, 49] . Under such conditions, activation of Ca 2+ channels may open ANO1 in rod bipolar cells resulting in an outward current that shortens Ca 2+ spike-like depolarizations or facilitates the repolarization of the cell membrane. Taken together, these results suggest that the physiologic function of ANO1 is dependent on Cl 2 distribution and the establishment of E Cl . ANO1 appears to confer an intrinsic electrical characteristic to retinal neurons and in the same way, may act as an important intrinsic regulator of the membrane potential in central neurons, including retinal neurons.
In addition, during synaptic transmission in rod bipolar axon terminals in which E Cl is more negative than the resting membrane potential, Cl 2 conductance stabilizes the presynaptic membrane potential, allowing an increase in glutamate release via an increase in [Ca 2+ ] i [19, 24] . Vesicle release is regulated by Ltype Ca 2+ channels, which in turn are regulated by Cl 2 moving through CaCCs, as reported at photoreceptor ribbon synapses [17, 18, 25, 38] . AII amacrine cells, which are located postsynaptically rod bipolar cells exhibit a mixture of transient and sustained components [50] [51] [52] . The transient component of the postsynaptic current is quite pronounced, whereas the sustained component is of relatively low amplitude [53] [54] [55] . This pattern is observed even in the presence of blockers of inhibitory GABAergic input and when only sustained Ca 2+ currents are activated in the rod bipolar cell, which suggests that glutamate release from mammalian rod bipolar cells is inherently transient [53, 56, 57] . In this study, a CaCC blocker and a selective ANO1 blocker prolonged the current-evoked depolarization in an isolated cell preparation without the synaptic network, suggesting that ANO1 function may be attributed to inherently transient glutamate release in rod bipolar cells.
Materials and Methods
Ethical standards
This study was carried out in strict accordance with the recommendations provided in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (NIH Publications No. 80-23; revised in 1996). The study protocol was approved by the Institutional Animal Care and Use Committee (IACUC) of the College of Medicine, The Catholic University of Korea (Approval Number: CUMS-2012-0087-01). All animal surgeries were performed under ketamine and xylazine anesthesia, and all efforts were made to minimize suffering.
Animals and tissue preparation
Three-month-old male C57BL/6 mice (Orient Bio, Seongnam, Korea) were used in this study. The mice were euthanized with 15% chloral hydrate.
For western blot analysis, the animals were transcardially perfused with saline, the eyeballs were enucleated, the anterior segments of the eyeballs were removed, and the retinal tissues were quickly dissected on an ice-cold plate, frozen on dry ice, and stored at 270uC.
For immunohistochemistry, the eyecups were fixed by immersion in 4% paraformaldehyde in 0.1 M phosphate buffer (PB, pH 7.4). After fixation, the retinas were carefully dissected and transferred to 30% sucrose in 0.1 M PB. They were then frozen in liquid nitrogen, thawed, and stored at 270uC.
For patch-clamp recordings, the retinas were quickly dissected and treated with a low-Ca 2+ solution containing 4 mg/mL of papain activated by 10 mM L110 cysteine. Subsequently, retinal cells were enzymatically isolated from retinas. The dissociated retinal preparations were kept in an oxygenated chamber during the recordings.
Antibodies
An anti-ANO1 polyclonal antibody (Cat. #LF-PA0208; Ab Frontier, Seoul, Korea) was raised in rabbits against a synthetic peptide with of amino acid sequence KDHPRAEYEARVLEKS (amino acids 451-466), which corresponded to a stretch located in the first intracellular loop between transmembrane domains 2 and 3 of mouse ANO1. The specificity of this antibody was tested by western blotting and immunocytochemical analyses in our previous study [7, 42] and demonstrated by immunohistochemistry in knockout animals [12] .
An anti-glial fibrillary acidic protein (GFAP) (Millipore, Temecula, CA) and peroxidase-conjugated donkey anti-rabbit (Molecular Probes, Eugene, OR) antibodies were used as controls in the patch-clamp recording experiment that was performed to test the neutralizing effect of the anti-ANO1 antibody. For doublelabeling, various antibodies were used to label presynaptic or postsynaptic elements and specific neurons in the retina. Their target structures, together with dilution rates, sources, companies, and references, are listed in Table S1 .
Western blotting
Western blot analysis was performed on extracts of the prepared tissues, which were homogenized in ice-cold RIPA buffer (50 mM Tris buffer, pH 8.0; 150 mM NaCl; 1% NP-40; 0.5% deoxycholate; and 0.1% SDS). Samples from each tissue (corresponding to 50 mg of total protein) were separated by SDS-PAGE, and the proteins were blotted onto a nitrocellulose membrane and probed with the anti-ANO1 antibody (dilution, 1:2000). The immunoreactive bands were detected using an Enhanced Chemiluminescence Detection Kit (Amersham, Arlington Heights, IL). Preincubation of the anti-ANO1 antibody with a 10-fold excess (w/w) of the antigenic peptide led to the absence of labeling in the subsequent western blot analysis (Fig. 1A) ; moreover, the reaction of the western blots with the secondary antibody alone produced no signal (data not shown).
Immunohistochemistry
Fifty-micrometer-thick vertical vibratome sections for the retina were used for immunohistochemistry. The sections were incubated in 10% normal donkey serum and incubated with the polyclonal antibody against ANO1 (dilution, 1:500) in 0.01 M phosphatebuffered saline (PBS, pH 7.4) containing 0.5% Triton X-100 for 1 day at 4uC. The sections were washed in PBS and incubated in the presence of biotin-labeled donkey anti-rabbit IgG (dilution, 1:100; Jackson Immuno Research, West Grove, PA) for 2 h. Subsequently, the sections were washed and incubated with Cy3-conjugated streptavidin in PBS (dilution, 1:1000; Jackson Immuno Research) for 1 h. The fluorescent specimens were mounted using Vectashield mounting medium (Vector Laboratories, Burlingame, CA). The specificity of the immunostaining was evaluated in retinal sections by preincubating the anti-ANO1 antibody with a 10-fold excess of its antigenic peptide for 1 h at room temperature (Fig. 1B) and by omitting the incubation step with the primary antibody (data not shown); no staining was observed in these sections.
For double-labeling experiments, the sections were incubated with antibody mixtures composed of the anti-ANO1 antibody and one of the marker antibodies, followed by incubation in the presence of appropriate secondary antibodies conjugated with Cy3 Digital images (1,02461,024 pixels) were acquired using a Zeiss LSM 510 Meta confocal microscope (Carl Zeiss Co. Ltd., Germany) and were imported into Photoshop (Adobe Systems, San Jose, CA). The brightness and contrast of the final images were adjusted.
Immunoelectron microscopy
Retinal sections were prepared as described above. After blocking, the sections were incubated in a solution containing the anti-ANO1 antibody at 4uC for 1 day, as described for light microscopy but without Triton X-100. The sections were washed in PBS for 45 min (3615 min), incubated with biotin-labeled donkey anti-rabbit IgG (dilution, 1:100; Jackson Immuno Research) for 2 h, and washed 3 times in PBS for 45 min (3615 min). The sections were then incubated in an avidin-biotinperoxidase complex (ABC) solution (Vector Laboratories) for 1 h, washed in 0.1 M Tris buffer (TB, pH 7.6), and preincubated in 0.05% 3,3'-diaminobenzidine tetrahydrochloride (DAB) in TB for 10 min, followed by incubation in the same solution containing 0.05% hydrogen peroxide (H 2 O 2 ) for an additional 10 min. The reaction was monitored using a low-power microscope and was stopped by replacing the DAB and H 2 O 2 solution with TB.
Stained sections were postfixed in 1% glutaraldehyde in PB for 1 h. After washing in PB containing 4.5% sucrose for 15 min (365 min), the sections were postfixed in 1% OsO 4 in PB for 1 h. Subsequently, the sections were rewashed in PB containing 4.5% sucrose and dehydrated in a graded series of ethanol. During the dehydration procedure, the sections were stained en bloc with 1% uranyl acetate in 70% alcohol for 1 h, then transferred to propylene oxide, and flat embedded in Epon 812. After curing at 60uC for 3 days, well-stained areas were cut out and attached to an Epon support for further ultrathin sectioning (Reichert-Jung, Nubloch, Germany). Serial ultrathin sections (70-90 nm in thickness) were collected on single slot grids, and examined using a JEM 1010 electron microscope (JEOL, Tokyo, Japan).
Patch-clamp recordings
Whole-cell recordings were performed on rod bipolar cells by using an EPC-9 amplifier and the PULSE software (Heka Electronik, Germany). Electrodes were fabricated from borosilicate microcapillary tubes (VWR Scientific, West Chester, PA) and fire-polished. The resistance of the electrode was 8-12 MV. Current signals were filtered at 3 kHz and digitized at 5 kHz by using a data-acquisition interface (LIH 1600 A/D board, HEKA). Cell membrane capacitance and series resistance current were automatically compensated by the amplifier using the software. The calculated liquid junction potential was also subtracted using this software. Data were analyzed offline by using the PULSE-fit and ORIGIN programs. Statistical analysis was performed using analysis of variance (ANOVA) and Student's t tests. Data are represented as means 6 S.D.. The differences were considered significant at P,0.05.
Pharmacology
Test solutions were mostly dissolved in the Ringer solution and applied locally to a whole-cell clamped cell from a puffer pipette via Y-tube system. All chemicals were purchased from SigmaAldrich (St Louis, MO), with the exception of 2-(5-ethyl-4-hydroxy-6-methylpyrimidin-2-ylthio)-N-(4-(4-methoxyphenyl)thiazol-2-yl)acetamide (T16A inh -A01) (Tocris, Ellisville, MI), DL-threob-benzyloxyaspartate (DL-tBOA) (Tocris), the anti-ANO1 antibody (Ab Frontier), and the anti-GFAP antibody (Millipore).
Some pharmacological agents were used for the manipulation of a specific ionic current: CoCl 2 [2-aminoethylether] -N,N,N9,N9-tetraacetic acid (EGTA), were applied in the pipette solution; when these agents were applied at higher concentration, the concentration of CsCl was appropriately reduced to adjust the osmolarity. 1,2-bis [2-aminophenoxy]ethane-N,N,N9,N9-tetraacetic acid tetrakis (BAPTA/AM), which is a cell-permeable Ca 2+ chelator, was applied extracellularly at 0.1 mM. To suppress Cl 2 conductance, several agents were applied, i.e., 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB), niflumic acid (NFA), 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS), and 4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid (SITS), to block Cl 2 channels selectively. T16A inh -A01 was tested as a specific ANO1 inhibitor.
DL-tBOA was used to suppress Cl 2 current mediated by the glutamate transporter. In addition, we tested the effects of blocking ANO1 by adding the specific anti-ANO1 antibody directly to the pipette solution. Both the anti-ANO1 and anti-GFAP antibodies were used at dilutions of 1:500 in the pipette solution. Author Contributions
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